Accomplished industry veterans help guide our company as we pioneer new paths in protein therapeutics discovery and development. Advisors from Biotech Investment Group (BIG) as well as individual, select consultants from various backgrounds comprise a significant pool of experience by our side.
BIOTECH INVESTMENT GROUP (BIG) BOARD AND COMPANY ADVISORS:
Biotech Investment Group is a provider of growth equity capital to emerging healthcare services companies. Their mission is to partner with outstanding entrepreneurs to build long lasting companies that address significant unmet healthcare needs.
Lee Babiss, PhD
You may know Lee from: Hoffman La Roche
Frederick Frank, MBA
You may know Frederick from: Peter J. Solomon Co., Barclays Capital, Lehman Brothers, Smith, Barney & Co.
Per Peterson, MD, PhD
You may know Per from: Johnson & Johnson, Scripps Clinic, Uppsala University
Eric Topol, MD
You may know Eric from: Scripps Clinic Translational Science Inst., Cleveland Clinic, CWRU, U. of Rochester, UCSF, John Hopkins, U. of Michigan
BioAtla founders – Masood Tayebi, PhD and Jay Short, PhD – also serve on the BIG Board.
BIOATLA KEY ADVISORS:
-
William J. Boyle, Ph.D.
You may know William from: VivaMab LLC, Peninsula Biopharma LLC, AnaptysBio, Auxeris Therapeutics, Protein Pathways, Amgen
John Burke, PhD, Esq.
You may know John from: Merchant & Gould, Deltagen, Pillsbury
Peter Emtage, PhD
You may know Peter from: Femta Pharmaceuticals, Nventa, Biomira, Nuvelo, Aventis Pasteur, Harvard, McMaster University
Eva Gregor, MS
You may know Eva from: Capia IP, Diversa, Trega, Alanex, Prake Davis, Dupont
Stephen Keane
You may know Stephen from: Femta Pharmaceuticals, Ambit Biosciences
Patrick McCroskey, PhD
You may know Patrick from: Texas Pacific Group, Ceres, Diversa, Dow
Larry Steinman, MD
You may know Larry from: Stanford University Neurology & Immunology, SUMC, NIH, Weizmann Institute of Science
Monica Sullivan
You may know Monica from: Capia IP, Diversa, Stratagene, UCSD